We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+21.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.2B
AUM Growth
+$6.6B
Cap. Flow
+$3.75B
Cap. Flow %
16.89%
Top 10 Hldgs %
18.16%
Holding
1,735
New
565
Increased
342
Reduced
340
Closed
467

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$239M
2
AAPL icon
Apple
AAPL
+$213M
3
ELV icon
Elevance Health
ELV
+$188M
4
BMY icon
Bristol-Myers Squibb
BMY
+$184M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$166M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$183M
2
ABBV icon
AbbVie
ABBV
+$149M
3
HUM icon
Humana
HUM
+$120M
4
FIS icon
Fidelity National Information Services
FIS
+$119M
5
MELI icon
Mercado Libre
MELI
+$103M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 17.93%
3 Consumer Discretionary 11.98%
4 Financials 8.85%
5 Communication Services 8.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UMPQ
1676
DELISTED
Umpqua Holdings Corp
UMPQ
– –
-185,711
Closed -$1.97M
ASAP
1677
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
– –
-18,205
Closed -$1.17M
TCDA
1678
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-28,886
Closed -$261K
TTM
1679
DELISTED
Tata Motors Limited
TTM
– –
-43,371
Closed -$394K
SWCH
1680
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-49,913
Closed -$780K
TWTR
1681
DELISTED
Twitter, Inc.
TWTR
– –
-79,618
Closed -$3.54M
Y
1682
DELISTED
Alleghany Corp
Y
– –
-5,915
Closed -$3.08M
GBT
1683
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-259,168
Closed -$14.3M
RTLR
1684
DELISTED
Rattler Midstream LP Common Units
RTLR
– –
-178,308
Closed -$1.06M
RDUS
1685
DELISTED
Radius Health, Inc.
RDUS
– –
-45,163
Closed -$511K
EPZM
1686
DELISTED
Epizyme, Inc
EPZM
– –
-10,358
Closed -$123K
WBT
1687
DELISTED
Welbilt, Inc.
WBT
– –
-131,839
Closed -$812K
CDK
1688
DELISTED
CDK Global, Inc.
CDK
– –
-50,252
Closed -$2.19M
ENIA
1689
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
– –
-26,528
Closed -$171K
CERN
1690
DELISTED
Cerner Corp
CERN
– –
-50,905
Closed -$3.68M
ATRS
1691
DELISTED
Antares Pharma, Inc.
ATRS
– –
-147,025
Closed -$396K
MIME
1692
DELISTED
Mimecast Limited
MIME
– –
-258,250
Closed -$12.1M
FOE
1693
DELISTED
Ferro Corporation
FOE
– –
-13,875
Closed -$172K
ISBC
1694
DELISTED
Investors Bancorp, Inc.
ISBC
– –
-73,118
Closed -$531K
ORPH
1695
DELISTED
Orphazyme A/S
ORPH
– –
-81,332
Closed -$840K
FRTA
1696
DELISTED
Forterra, Inc
FRTA
– –
-40,548
Closed -$479K
VCRA
1697
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
– –
-81,066
Closed -$2.36M
OTLKW
1698
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
– –
-125,400
Closed -$20.9K
GWB
1699
DELISTED
Great Western Bancorp, Inc.
GWB
– –
-60,290
Closed -$751K
CSPR
1700
DELISTED
Casper Sleep Inc.
CSPR
– –
-10,847
Closed -$78K
66 67
68
69 70

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace North America held 1,735 positions worth $22.2B, up 42% from $15.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace North America deployed $3.75B of net new capital in Q4 2020, opening 565 new positions and adding to 342 existing holdings. Its largest new stake was ExxonMobil: 2,686,885 shares worth $111M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Adobe, an estimated $183M trimmed.

  • Marshall Wace North America's largest Q4 2020 buy was ExxonMobil: 2,686,885 shares worth $111M.
  • Marshall Wace North America added most to Thermo Fisher Scientific in Q4 2020, an estimated $239M increase.
  • Marshall Wace North America's biggest Q4 2020 reduction was Adobe, cutting an estimated $183M.
  • Marshall Wace North America fully exited Baxter International in Q4 2020, selling an estimated $92.8M.
  • Marshall Wace North America's ten largest holdings make up 18% of its $22.2B portfolio in Q4 2020.
  • Marshall Wace North America opened 565 new positions and closed 467 in Q4 2020.
  • Marshall Wace North America's portfolio value rose 42% quarter-over-quarter to $22.2B.

Based on Marshall Wace North America's 13F filing for Q4 2020, filed 16 Feb 2021.